The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma
Abstract
MicroRNAs (miRs) are non-coding RNA molecules involved in cancer initiation and progression. Deregulated miR expression has been implicated in cancer; however, there are no studies implicating an miR signature associated with progression in oral squamous cell carcinoma (OSCC). Although OSCC may develop from oral leukoplakia, clinical and histological assessments have limited prognostic value in predicting which leukoplakic lesions will progress. Our aim was to quantify miR expression changes in leukoplakia and same-site OSCC and to identify an miR signature associated with progression. We examined miR expression changes in 43 sequential progressive samples from 12 patients and four non-progressive leukoplakias from four different patients, using TaqMan Low Density Arrays. The findings were validated using quantitative RT-PCR in an independent cohort of 52 progressive dysplasias and OSCCs, and five non-progressive dysplasias. Global miR expression profiles distinguished progressive leukoplakia/OSCC from non-progressive leukoplakias/normal tissues. One hundred and nine miRs were highly expressed exclusively in progressive leukoplakia and invasive OSCC. miR-21, miR-181b and miR-345 expressions were consistently increased and associated with increases in lesion severity during progression. Over-expression of miR-21, miR-181b and miR-345 may play an important role in malignant transformation. Our study provides the first evidence of an miR signature potentially useful for identifying leukoplakias at risk of malignant transformation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,095
miRBase: microRNA sequences, targets and gene nomenclature
Griffiths-Jones, S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj112 · Cited by 3,950
Parkin, D. M., Pisani, P., & Ferlay, J. (1999) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.49.1.33 · Cited by 3,376
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., Stephens, R. M., Okamoto, A., Yokota, J., Tanaka, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.025 · Cited by 3,023
MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells
Chan, J. A., Krichevsky, A. M., & Kosik, K. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0137 · Cited by 2,557
A MicroRNA Signature Associated with Prognosis and Progression in Chronic Lymphocytic Leukemia
Calin, G. A., Ferracin, M., Cimmino, A., Di Leva, G., Shimizu, M., Wojcik, S. E., Iorio, M. V., Visone, R., Sever, N. I., Fabbri, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050995 · Cited by 2,403
Brennecke, J., Hipfner, D. R., Stark, A., Russell, R. B., & Cohen, S. M. (2003) · Cell · doi:10.1016/s0092-8674(03)00231-9 · Cited by 2,042
Nomenclature and classification of potentially malignant disorders of the oral mucosa
Warnakulasuriya, S., Johnson, N. W., & Van Der Waal, I. (2007) · Journal of Oral Pathology & Medicine · doi:10.1111/j.1600-0714.2007.00582.x · Cited by 1,762
Schetter, A. J., Leung, S. Y., Sohn, J. J., Zanetti, K. A., Bowman, E. D., Yanaihara, N., Yuen, S. T., Chan, T. L., Kwong, D. L. W., Au, G. K. H., et al. (2008) · JAMA · doi:10.1001/jama.299.4.425 · Cited by 1,578
Genetic progression model for head and neck cancer: implications for field cancerization.
Califano, J. A., van der Riet, P., Westra, W. H., Nawroz, H., Clayman, G. L., Piantadosi, S., Corio, R. L., Lee, D. J., Greenberg, B. M., Koch, W. M., et al. (1996) · PubMed · Cited by 1,355
Yan, L.-X., Huang, X.-F., Shao, Q., Huang, M.-Y., Deng, L., Wu, Q.-L., Zeng, Y.-X., & Shao, J.-Y. (2008) · RNA · doi:10.1261/rna.1034808 · Cited by 1,148
Extensive modulation of a set of microRNAs in primary glioblastoma
Ciafrè, S. A., Galardi, S., Mangiola, A., Ferracin, M., Liu, C.-G., Sabatino, G., Negrini, M., Maira, G., Croce, C. M., & Farace, M. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.030 · Cited by 1,096 · cited 1×
“miR-181b is frequently up-regulated in B-cell chronic lymphocytic leukemias (26), brain tumors (27), thyroid (28) and gastro-intestinal carcinomas (29).”
MicroRNA-21 Targets the Tumor Suppressor Gene Tropomyosin 1 (TPM1)
Zhu, S., Si, M.-L., Wu, H., & Mo, Y.-Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611393200 · Cited by 1,090
MicroRNA-21 targets tumor suppressor genes in invasion and metastasis
Zhu, S., Wu, H., Wu, F., Nie, D., Sheng, S., & Mo, Y.-Y. (2008) · Cell Research · doi:10.1038/cr.2008.24 · Cited by 1,051
miR‐21: a small multi‐faceted RNA
Krichevsky, A. M., & Gabriely, G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00556.x · Cited by 987
MicroRNA Expression Profiling in Prostate Cancer
Porkka, K. P., Pfeiffer, M. J., Waltering, K. K., Vessella, R. L., Tammela, T. L. J., & Visakorpi, T. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0533 · Cited by 899
Expression profiling identifies microRNA signature in pancreatic cancer
Lee, E. J., Gusev, Y., Jiang, J., Nuovo, G. J., Lerner, M. R., Frankel, W. L., Morgan, D. L., Postier, R. G., Brackett, D. J., & Schmittgen, T. D. (2007) · International Journal of Cancer · doi:10.1002/ijc.22394 · Cited by 896
MicroRNA-21 targets tumor suppressor genes in invasion and metastasis
Shuomin, Zhu, Hailong, H., Wu, Fangting, Daotai, Nie, Shijie, Sheng, Yin-Yuan, et al. (2008) · Cell Research · Cited by 831
Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue
Wong, T.-S., Liu, X.-B., Wong, B. Y.-H., Ng, R. W.-M., Yuen, A. P.-W., & Wei, W. I. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0666 · Cited by 750
OncomiRs: the discovery and progress of microRNAs in cancers
Cho, W. C. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-60 · Cited by 719
MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene
Lu, Z., Liu, M., Stribinskis, V, Klinge, C. M., Ramos, K. S., Colburn, N. H., & Li, Y. (2008) · Oncogene · doi:10.1038/onc.2008.72 · Cited by 711
Stem cell division is regulated by the microRNA pathway
Hatfield, S. D., Shcherbata, H. R., Fischer, K. A., Nakahara, K., Carthew, R. W., & Ruohola-Baker, H. (2005) · Nature · doi:10.1038/nature03816 · Cited by 674
MicroRNA Expression Profiling of Thyroid Tumors: Biological Significance and Diagnostic Utility
Nikiforova, M. N., Tseng, G. C., Steward, D., Diorio, D., & Nikiforov, Y. E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2696 · Cited by 582
The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation
Naguibneva, I., Ameyar-Zazoua, M., Polesskaya, A., Ait-Si-Ali, S., Groisman, R., Souidi, M., Cuvellier, S., & Harel-Bellan, A. (2006) · Nature Cell Biology · doi:10.1038/ncb1373 · Cited by 578
Reibel, J. (2003) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/154411130301400105 · Cited by 553
MicroRNA deregulation in human thyroid papillary carcinomas
Pallante, P., Visone, R., Ferracin, M., Ferraro, A., Berlingieri, M. T., Troncone, G., Chiappetta, G., Liu, C. G., Santoro, M., Negrini, M., et al. (2006) · Endocrine-Related Cancer · doi:10.1677/erc.1.01209 · Cited by 527
A high-throughput method to monitor the expression of microRNA precursors
Schmittgen, T. D. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh040 · Cited by 483
Perry, M. M., Moschos, S. A., Williams, A. E., Shepherd, N. J., Larner-Svensson, H. M., & Lindsay, M. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5689 · Cited by 461
Long-term treatment outcome of oral premalignant lesions
Holmstrup, P., Vedtofte, P., Reibel, J., & Stoltze, K. (2006) · Oral Oncology · doi:10.1016/j.oraloncology.2005.08.011 · Cited by 443
Predicting cancer development in oral leukoplakia: ten years of translational research.
Lee, J. J., Hong, W. K., Hittelman, W. N., Mao, L., Lotan, R., Shin, D. M., Benner, S. E., Xu, X. C., Lee, J. S., Papadimitrakopoulou, V., et al. (2000) · PubMed · Cited by 425
MicroRNA-21 is Overexpressed in Pancreatic Cancer and a Potential Predictor of Survival
Dillhoff, M., Liu, J., Frankel, W., Croce, C., & Bloomston, M. (2008) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-008-0584-x · Cited by 408
MicroRNA Classifiers for Predicting Prognosis of Squamous Cell Lung Cancer
Raponi, M., Dossey, L., Jatkoe, T., Wu, X., Chen, G., Fan, H., & Beer, D. G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0587 · Cited by 399
Probing microRNAs with microarrays: tissue specificity and functional inference
BABAK, T., ZHANG, W., MORRIS, Q., BLENCOWE, B. J., & HUGHES, T. R. (2004) · RNA · doi:10.1261/rna.7119904 · Cited by 385
Prediction and validation of microRNAs and their targets
Bentwich, I. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.09.040 · Cited by 369
Garzon, R., Pichiorri, F., Palumbo, T., Visentini, M., Aqeilan, R., Cimmino, A., Wang, H., Sun, H., Volinia, S., Alder, H., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210186 · Cited by 362
Chen, Y., & Stallings, R. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3667 · Cited by 326
Inflammation in the development of lung cancer: epidemiological evidence
Engels, E. A. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.4.605 · Cited by 299
Arceci, R. J. (2008) · Yearbook of Oncology · doi:10.1016/s1040-1741(08)79165-6 · Cited by 299
MicroRNA expression profiles in head and neck cancer cell lines
Tran, N., McLean, T., Zhang, X., Zhao, C. J., Thomson, J. M., O’Brien, C., & Rose, B. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.201 · Cited by 275
MicroRNA Expression Ratio Is Predictive of Head and Neck Squamous Cell Carcinoma
Avissar, M., Christensen, B. C., Kelsey, K. T., & Marsit, C. J. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3131 · Cited by 270
MicroRNA alterations in head and neck squamous cell carcinoma
Chang, S. S., Jiang, W. W., Smith, I., Poeta, L. M., Begum, S., Glazer, C., Shan, S., Westra, W., Sidransky, D., & Califano, J. A. (2008) · International Journal of Cancer · doi:10.1002/ijc.23831 · Cited by 268
Oncogenic Potential of the miR-106-363 Cluster and Its Implication in Human T-Cell Leukemia
Landais, S., Landry, S., Legault, P., & Rassart, E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4478 · Cited by 241
Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues
Hui, A. B. Y., Shi, W., Boutros, P. C., Miller, N., Pintilie, M., Fyles, T., McCready, D., Wong, D., Gerster, K., Jurisica, I., et al. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.12 · Cited by 232
Self-citationDoleshal, M., Magotra, A. A., Choudhury, B., Cannon, B. D., Labourier, E., & Szafranska, A. E. (2008) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2008.070153 · Cited by 229
MicroRNA: Biogenetic and Functional Mechanisms and Involvements in Cell Differentiation and Cancer
Tsuchiya, S., Okuno, Y., & Tsujimoto, G. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.cpj06013x · Cited by 130
A transcriptional progression model for head and neck cancer.
Ha, P. K., Benoit, N. E., Yochem, R. L., Sciubba, J. J., ZAHURAK, M. L., Sidransky, D., Pevsner, J., Westra, W. H., & Califano, J. A. (2003) · PubMed · Cited by 126
Sadiković, B., Yoshimoto, M., Al-Romaih, K. I., Maire, G., Zieleńska, M., & Squire, J. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002834 · Cited by 77
Unlocking pathology archives for microRNA-profiling.
Hoefig, K. P., Thorns, C., Roehle, A., Kaehler, C., Wesche, K. O., Repsilber, D., Branke, B., Thiere, M., Feller, A. C., & Merz, H. (2008) · PubMed · Cited by 55
Investigation of MicroRNA Alterations in Leukemias and Lymphomas
Calin, G. A., & Croce, C. M. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)27011-9 · Cited by 39
Cited by
The molecular biology of head and neck cancer
Leemans, C. R., Braakhuis, B. J. M., & Brakenhoff, R. H. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2982 · Cited by 2,524
Iliopoulos, D., Jaeger, S. A., Hirsch, H. A., Bulyk, M. L., & Struhl, K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.07.023 · Cited by 830
“In accordance with previous work, RNA levels of STAT3 (Iliopoulos et al., 2009; Bromberg et al., 1999; Grivennikov et al., 2009), miR-21, and miR-181b-1 (Schetter et al., 2008; Yan et al., 2008; Cervigne et al., 2009) are often increased in cancer tissues relative to normal tissues.”
BackgroundInfluentialMa, X., Becker Buscaglia, L. E., Barker, J. R., & Li, Y. (2011) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjr007 · Cited by 542
mRNA transcript quantification in archival samples using multiplexed, color-coded probes
Reis, P. P., Waldron, L., Goswami, R. S., Xu, W., Xuan, Y., Perez-Ordonez, B., Gullane, P., Irish, J., Jurisica, I., & Kamel-Reid, S. (2011) · BMC Biotechnology · doi:10.1186/1472-6750-11-46 · Cited by 283
Self-citationEngineering CHO cell growth and recombinant protein productivity by overexpression of miR-7
Barron, N., Kumar, N., Sanchez, N., Doolan, P., Clarke, C., Meleady, P., O'Sullivan, F., & Clynes, M. (2011) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.12.005 · Cited by 110
Metadata
- Authors
- Cervigne, N. K., Reis, P. P., Machado, J., Sadikovic, B., Bradley, G., Galloni, N. N., Pintilie, M., Jurisica, I., Perez-Ordonez, B., Gilbert, R., Gullane, P., Irish, J., & Kamel-Reid, S.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-09-23
- Volume
- 18
- Issue
- 24
- Pages
- 4818-4829
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2125054984
- Cited by
- 268
- References
- 56
- FWCI
- 6.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.